Since CS induces an elevated release of inflammatory mediators such as cytokines [interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α)] and reactive oxygen species (ROS) in the lung, CS can be considered the primary risk factor for COPD (Barnes, 2004). Here, IL6 is linked to chronic obstructive pulmonary disease.